Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory of Cyto- |
RCV001843689 | SCV002102799 | likely pathogenic | Autosomal dominant distal renal tubular acidosis | 2022-03-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002543276 | SCV003703107 | uncertain significance | Inborn genetic diseases | 2022-03-23 | criteria provided, single submitter | clinical testing | The c.2656C>A (p.L886M) alteration is located in exon 20 (coding exon 19) of the SLC4A1 gene. This alteration results from a C to A substitution at nucleotide position 2656, causing the leucine (L) at amino acid position 886 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005006085 | SCV005640011 | uncertain significance | BLOOD GROUP--SWANN SYSTEM; BLOOD GROUP--WALDNER TYPE; BLOOD GROUP--FROESE; BLOOD GROUP--WRIGHT ANTIGEN; Southeast Asian ovalocytosis; Hereditary spherocytosis type 4; BLOOD GROUP--DIEGO SYSTEM; Cryohydrocytosis; Autosomal dominant distal renal tubular acidosis; Renal tubular acidosis, distal, 4, with hemolytic anemia; Malaria, susceptibility to | 2024-03-26 | criteria provided, single submitter | clinical testing |